Catalyst
Slingshot members are tracking this event:
Zogenix Announces Top-line Results from Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ZGNX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 29, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Zx008, Dravet Syndrome, Epilepsy
